Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
Cardiac fibrosis is associated with most forms of cardiovascular disease. No reliable therapies targeting cardiac fibrosis are available, thus identifying novel drugs that can resolve or prevent fibrosis is needed. Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung disease....
Saved in:
Main Authors: | Duncan Horlock (Author), David M. Kaye (Author), Catherine E. Winbanks (Author), Xiao-Ming Gao (Author), Helen Kiriazis (Author), Daniel G. Donner (Author), Paul Gregorevic (Author), Julie R. McMullen (Author), Bianca C. Bernardo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Self-Assembling Injectable Hydrogel for Controlled Drug Delivery of Antimuscular Atrophy Drug Tilorone
by: Mohamed M. Abdelghafour, et al.
Published: (2022) -
dsRNA as broad-spectrum antiviral therapeutics
by: Congfei Xu
Published: (2022) -
Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats
by: Viktoriya Keyer, et al.
Published: (2022) -
Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
by: Bianca C. Bernardo, et al.
Published: (2018) -
Human helicase DDX3 as target for broad-spectrum antivirals against pandemic and emerging viruses
by: Annalaura Brai, et al.
Published: (2016)